MissionIR Articles

Double Eagle Petroleum Co. today reported record financial results for the full-year 2008. Net income attributable to common shareholders totaled $6,658,000, or $0.73 per diluted share, as compared to a net loss of $(13,413,000), or…

Reed’s, Inc. recently exhibited at the Natural Products Expo West, the largest show of its kind on the West Coast. The company’s management team and sales staff were present to promote Reed’s Ginger Brew and…

IDM Pharma, Inc. announced that the European Commission has formally authorized MEPACT® (mifamurtide, L-MTP-PE) for the treatment of patients with non-metastatic, resectable osteosarcoma, a rare and often fatal bone tumor. MEPACT can now be marketed…

American Oriental Bioengineering, Inc, (NYSE:AOB) announced today that its fourth quarter 2008 revenues were up a whopping 68% to $96.3 million. Net income for the same period was up 43% to $21.7 million. The good…

Evotec AG announced that it has appointed Dr. Werner Lanthaler as its Chief Executive Officer, effective immediately. Previously, Dr. Lanthaler was Chief Financial Officer of Intercell AG in Vienna, Austria, a global biopharmaceutical leader focused…

Solutia Inc. announced this morning that it is re-affirming its full-year 2009 adjusted EBITDA guidance from continuing operations of $325 million to $350 million and its full-year 2009 total cash from operations less capital expenditures…

Unlike the “Big Three,” China Automotive Systems, Inc. has been doing quite well recently and expects its subsidiary, Jingzhou Henglong Automotive Parts Co., Ltd. (“Henglong”), to have a record monthly production of 85,000 power steering…

eSolar, manufacturer of scalable, modular solar power collection plants, reported today the signing of an exclusive agreement with the ACME Group, one of India’s leading environmentally-conscious energy companies. eSolar utilizes specialized solar thermal energy technology…

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research development, manufacture and commercialization of vaccines that protect against human infectious diseases. While the young company is already renowned for being a…

Pluristem Therapeutics Inc. announced that the US Food & Drug Administration (FDA) has given the company clearance to begin a Phase I clinical trial for the treatment of Critical Limb Ischemia (CLI), the end stage…